Papers by Francesco Cappelli
8 results
- Cardiology and Therapy
Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy
Cohort study of 1,924 peopleInterventions - Journal of the American Heart Association
Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial
Trial in peopleBiomarkers - Journal of the American College of Cardiology
Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis
Trial in peopleInterventions
- AHA Scientific Sessions 2025 Abstract
Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results From the ATTRibute-CM Study
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Acoramidis Improved Clinical Outcomes, Function, Quality of Life and NT-proBNP in Patients With Transthyretin Amyloid Cardiomyopathy Regardless of Atrial Fibrillation Status at Baseline
Trial in peopleInterventions